N3-methyladenine induces early poly(ADP-ribosylation), reduction of nuclear factor-κB DNA binding ability, and nuclear up-regulation of telomerase activity

Molecular Pharmacology

Volumn 67, Issue 2, 2005, Pages 572-581

  Tentori, Lucio ^a   Forini, Olindo ^a   Fossile, Emanuela ^a   Muzi, Alessia ^a   Vergati, Matteo ^a   Portarena, Ilaria ^a   Amici, Carla ^a   Gold, Barry ^b   Graziani, Grazia ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOBENZAMIDE; 3 METHYLADENINE; 8 HYDROXY 2 METHYL 4(3H) QUINAZOLINONE; ADENOSINE DIPHOSPHATE RIBOSE; ANTINEOPLASTIC AGENT; DNA; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEXITROPSIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); POLY(ADP RIBOSE)POLYMERASE INHIBITOR; TELOMERASE; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; CONTROLLED STUDY; CYTOSOL; DNA BINDING; DNA DAMAGE; ENZYME ACTIVITY; ENZYME INHIBITION; EXCISION REPAIR; GENOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NECROSIS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADENINE; CELL LINE, TUMOR; CELL NUCLEUS; DNA; ENZYME ACTIVATION; HUMANS; NF-KAPPA B; POLY ADENOSINE DIPHOSPHATE RIBOSE; PROTEIN BINDING; TELOMERASE; UP-REGULATION;

EID: 13444282652     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.004937     Document Type: Article

References (39)

1. Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC, and Anderson KC (2003) Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res 63:18-21.
2. + depletion and mitochondrial permeability transition. J Biol Chem 279:18895-18902.
3. Amici C, Belardo G, Rossi A, and Santoro MG (2001) Activation of IκB kinase by Herpes Simplex virus type 1. A novel target for anti-herpetic therapy. J Biol Chem 276:28759-28766.
4. Birkenkamp KU, Geugien M, Schepers H, Westra J, Lemmink HH, and Vellenga E (2004) Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway. Leukemia 18:103-112.
5. Chang WJ and Alvarez-Gonzalez R (2001) The sequence-specific DNA binding of NF-κB is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1. J Biol Chem 276:47664-47670.
6. Das KC and White CW (1997) Activation of NF-κB by antineoplastic agents. Role of protein kinase C. J Biol Chem 272:14914-14920.
7. D'Atri S, Tentori L, Lacal PM, Graziani G, Pagani E, Benincasa E, Zambruno G, Bonmassar E, and Jiricny J (1998) Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol Pharmacol 54:334-341.
8. Drummond JT, Genschel J, Wolf E, and Modrich P (1997) DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSalpha/hMutSbeta ratio and reduces the efficiency of base-base mismatch repair. Proc Natl Acad Sci USA 94:10144-10149.
9. Encell L, Shuker DE, Foiles PG, and Gold B (1996) The in vitro methylation of DNA by a minor groove binding methyl sulfonate ester. Chem Res Toxicol 9:563-567.
10. Fronza G and Gold B (2004) The biological effects of N3-methyladenine. J Cell Biochem 91:250-257.
11. Ha HC and Snyder SH (1999) Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 96:13978-13982.
12. Hassa PO, Buerki C, Lombardi C, Imhof R, and Hottiger MO (2003) Transcriptional coactivation of nuclear factor-κB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J Biol Chem 278:45145-45153.
13. Hassa PO, Covic M, Hasan S, Imhof R, and Hottiger MO (2001) The enzymatic and DNA binding activity of PARP-1 are not required for NF-κB coactivator function. J Biol Chem 276:45588-45597.
14. Karin M, Yamamoto Y, and Wang QM (2004) The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 3:17-26.
15. Kataoka A, Kubota M, Wakazono Y, Okuda A, Bessho R, Lin YW, Usami I, Akiyama Y, and Furusho K (1995) Association of high molecular weight DNA fragmentation with apoptotic or non-apoptotic cell death induced by calcium ionophore. FEBS Lett 364:264-267.
16. Klapper W, Qian W, Schulte C, and Parwaresch R (2003) DNA damage transiently increases TRF2 mRNA expression and telomerase activity. Leukemia 17:2007-2015.
17. Kyo S, Masutomi K, Maida Y, Kanaya T, Yatabe N, Nakamura M, Tanaka M, Takarada M, Sugawara I, Murakami S, et al. (2003) Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase. Am J Pathol 163:859-867.
18. Kyrtopoulos SA, Anderson LM, Chhabra SK, Souliotis VL, Pletsa V, Valavanis C, and Georgiadis P (1997) DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance. Cancer Detect Prev 21:391-405.
19. Levati L, Marra G, Lettieri T, D'Atri S, Vernole P, Tentori L, Lacal PM, Pagani E, Bonmassar E, Jiricny J, et al. (1998) Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemic line tolerant to methylating agents. Gene Chromosome Cancer 3:159-166.
20. Liu L, Markowitz S, and Gerson SL (1996) Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res 56:5375-5379.
21. Mizumoto K and Farber JL (1995) Growth inhibition and cell killing by N-methyl-N-nitrosourea: metabolic alterations that accompany poly(ADP-ribosyl)ation. Arch Biochem Biophys 319:512-518.
22. Moriarty TJ, Dupuis S, and Autexier C (2002) Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide. Leukemia 16:1112-1120.
23. Neuhof D, Ruess A, Wenz F, and Weber KJ (2001) Induction of telomerase activity by irradiation in human lymphoblasts. Radiat Res 155:693-697.
24. Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT, and Brock C (1997) Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 23:35-61.
25. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, and de Murcia G (1999) Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO (Eur Mol Biol Organ) J 18:4446-4454.
26. Sato N, Mizumoto K, Kusumoto M, Nishio S, Maehara N, Urashima T, Ogawa T, and Tanaka M (2000) Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide. Br J Cancer 82:1819-1826.
27. Shah GM, Kaufmann SH, and Poirier GG (1995) Detection of poly(ADP-ribose) polymerase and its apoptosis-specific fragment by a nonisotopic activity-Western blot technique. Anal Biochem 232:251-254.
28. Shin KH, Kang MK, Dicterow E, Kameta A, Baluda MA, and Park NH (2004) Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity. Clin Cancer Res 10:2551-2560.
29. Slagsvold HH, Rosseland CM, Jacobs C, Khuong E, Kristoffersen N, Gaarder M, Fallgren AB, Huitfeldt HS, and Paulsen RE (2003) High molecular weight DNA fragments are processed by caspase sensitive or caspase independent pathways in cultures of cerebellar granule neurons. Brain Res 984:111-121.
30. Srivastava D, Berg BJ, Prasad R, Molina JT, Beard WA, Tomkinson AE, and Wilson SH (1998) Mammalian abasic site base excision repair Identification of the reaction sequence and rate-determining steps. J Biol Chem 273:21203-21209.
31. Tentori L, Vernole P, Lacal PM, Madaio R, Portarena I, Levati L, Balduzzi A, Turriziani M, Dande P, Gold B, et al. (2000) Cytotoxic and clastogenic effects of a DNA minor groove binding methyl sulfonate ester in mismatch repair deficient leukemic cells. Leukemia 14:1451-1459.
32. Tentori L, Balduzzi A, Portarena I, Levati L, Vernole P, Gold B, Bonmassar E, and Graziani G (2001) Poly (ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester. Cell Death Differ 8:817-828.
33. Tentori L, Leonetti C, Scarsella M, d'Amati G, Portarena I, Zupi G, Bonmassar E, and Graziani G (2002) Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site. Blood 99:2241-2244.
34. Tentori L, Leonetti C, Scarsella M, D'Amati G, Vergati M, Portarena I, Xu W, Kalish V, Zupi G, Zhang J, et al. (2003) Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma. Clin Cancer Res 9:5370-5379.
35. Yin L, Hubbard AK, and Giardina C (2000) NF-κB regulates transcription of the mouse telomerase catalytic subunit. J Biol Chem 275:36671-36675.
36. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, and Dawson VL (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science (Wash DC) 297:259-263.
37. Virag L, Salzman AL, and Szabo C (1998) Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol 161:3753-3759.
38. Zaninoni A, Imperiali FG, Pasquini C, Zanella A, and Barcellini W (2003) Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia. Exp Hematol 31:185-190.
39. Zhang Y, Chen F-X, Mehta P, and Gold B (1993) The design of groove and sequence selective alkylation of DNA by sulfonate esters tethered to lexitropsin. Biochemistry 32:7954-7965.